Advertisement
Biopharmaceutical Processing
Subscribe to Biopharmaceutical Processing

The Lead

AbbVie completes acquisition of Pharmacyclics

May 26, 2015 10:55 am | by PRNewswire | News | Comments

"The companies' shared expertise, combined with AbbVie's broad late-stage oncology pipeline, has the potential to transform the cancer treatment landscape for hematological malignancies and improve patient outcomes and quality of life," said Richard A. Gonzalez, chairman and chief executive officer, AbbVie. 

Tanner, BurnsAdler Merge to Form New Group

May 26, 2015 10:49 am | by Business Wire | News | Comments

The newly formed Tanner Pharma Group will continue to focus on patients by providing...

Eagle Pharmaceuticals Receives Patent for Rapid Infusion Product

May 19, 2015 8:59 am | by Business Wire | News | Comments

Eagle Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office...

TRACON Q1 Results

May 14, 2015 11:29 am | by TRACON Pharmaceuticals | News | Comments

TRACON Pharmaceuticals, a clinical stage biopharmaceutical company, today announced its...

View Sample

FREE Email Newsletter

SAFC Expands in St. Louis

May 13, 2015 11:43 am | by Sigma-Aldrich Corporation | News | Comments

Sigma-Aldrich Corporation has completed the expansion of its St. Louis facility to support commercial-scale antibody drug conjugate (ADC) manufacturing.

Pfizer Acquires Minority Interest in AM-Pharma

May 12, 2015 11:41 am | by Pfizer | News | Comments

Pfizer recently announced their acquisition of a minority equity interest in AM-Pharma, and secured an exclusive option to acquire the remaining equity in the company.

SAFC Expands Gene Therapy Facility

May 12, 2015 11:37 am | by Sigma-Aldrich Corporation | News | Comments

Sigma-Aldrich Corporation's new facility will support commercial-scale gene therapy production, testing and filling.

Advertisement

Juno Acquires Stage Cell

May 12, 2015 11:15 am | by Juno Therapeutics | News | Comments

Juno Therapeutics, a biopharmaceutical company focused on cancer treatment, announced today that it has acquired Stage Cell Therapeutics GmbH.

Inovio Unveils Clinical Trial for Ebola Immunotherapy

May 12, 2015 11:06 am | by Inovio Pharmaceuticals | News | Comments

Inovio Pharmaceuticals announced that the company has initiated a phase I trial to evaluate the safety, tolerability and immune responses of their DNA immunotherapy for Ebola.

2 Dead, 29 Sickened From Bad Vaccines

May 11, 2015 11:00 am | by The Associated Press | News | Comments

Mexico's public health system has suspended infant vaccines and mounted an investigation after vaccinations for tuberculosis, rotovirus and Hepatitis B resulted in devestation for an impoverished southern community.

Rexahn Pharmaceuticals Updates Pipeline

May 11, 2015 10:34 am | by Rexahn Pharmaceuticals | News | Comments

Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing therapeutics for the treatment of cancer provided an update of its three clinical development programs.

Bellicum Leases Space for Pilot Manufacturing Facility

May 8, 2015 11:43 am | by Bellicum Pharmaceuticals | News | Comments

Bellicum Pharmaceuticals, Inc. today announced that it has entered into a lease agreement to enable in-house cell therapy manufacturing to supply clinical trials.

Advertisement

MorphoSys Acquires Lanthio Pharma

May 7, 2015 11:16 am | by MorphoSys AG | News | Comments

MorphoSys AG announced today that it has acquired all outstanding shares of the Dutch biopharmaceutical company Lanthio Pharma B.V.

Alexion Pharma to Pay $8.4 Billion for Synageva BioPharma

May 6, 2015 11:14 am | by Tom Murphy, AP Business Writer | News | Comments

Alexion Pharmaceuticals will pay a huge premium to buy fellow rare disease treatment maker Synageva BioPharma in an $8.4-billion deal for a company with no products on the market.

PlasmaTech Acquires Abeona

May 6, 2015 11:08 am | News | Comments

PlasmaTech Biopharmaceuticals has acquired Abeona Therapeutics, a company engaged in the development and commercialization of therapies for patients with lysosomal storage diseases.

Amyris Unveils Q1 Results

May 6, 2015 10:47 am | by Amyris | News | Comments

Amyris, Inc., the industrial bioscience company, today announced financial results for the first quarter of 2015.

Dock Management: Sealing The Perimeter

May 5, 2015 10:35 am | by Mary Blaser, Director of Marketing and Business Development, Rite-Hite Environmental Enclosures Corporation | Blogs | Comments

While it’s a vital link between a facility and the pharmaceuticals shipped in and out every day, the loading dock presents the greatest opportunity for energy losses and damage to precious materials and products.

Advertisement

How Shared Service Management Can Help Make Your Organization Lean

May 5, 2015 10:26 am | by Nancy Van Elsacker, President, TOPdesk | Blogs | Comments

Shared service management is an important development in the collaboration between an organization’s supporting services, and can make an organization more Lean.

BioPharma Industry Seeks Downstream Processing Advances

May 5, 2015 10:12 am | by Eric S. Langer, President, BioPlan Associates | Blogs | Comments

Downstream processing continues to impact capacity at the majority of biopharmaceutical manufacturing facilities.

Ciclofilin Pharmaceuticals Appoints New President

May 4, 2015 11:52 am | by Ciclofilin Pharmaceuticals | News | Comments

Ciclofilin Pharmaceuticals Inc., a hepatitis B virus ("HBV") drug developer, announced today the appointment of Michael Kamdar as President.

Oncobiologics Opens Manufacturing Facility in New Jersey

May 4, 2015 11:48 am | by Oncobiologics | News | Comments

The GMP commercial launch manufacturing facility in Cranbury will focus on antibody biosimilars.

Capsugel Expanding Lung Biotherapeutics Trial

May 4, 2015 11:40 am | by Capsugel | News | Comments

Capsugel has manufactured Phase 2 clinical trial supplies for a dry powder inhalation (DPI) formulation that efficiently delivers biotherapeutics to the lung.

Immune Pharmaceuticals and STC Biologics Announce Strategic Partnership

May 4, 2015 11:34 am | by Immune Pharmaceuticals | News | Comments

Immune Pharmaceuticals and STC Biologics are entering into a strategic partnership to accelerate the development of NanomAbs, a new generation of Antibody Nanoparticle Conjugates allowing the targeted delivery of chemo-therapeutics.

SAFC Launches ADC Express

May 1, 2015 11:03 am | by Sigma-Aldrich | News | Comments

Sigma-Aldrich Corporation today announced that SAFC Commercial, its custom manufacturing services business unit, has introduced ADC Express preclinical development services.

TESARO Announces Q1 Operating Results

May 1, 2015 10:53 am | by TESARO | News | Comments

TESARO, Inc., an oncology-focused biopharmaceutical company, today reported operating results for first-quarter 2015 and provided an update on the Company's development programs.

Pipeline Investments, Acquisitions Fueling Biotech

April 30, 2015 11:07 am | by GlobalData | News | Comments

The spend on R&D for mid-cap biotech companies increased by nearly $2 billion to reach a total of $9.7 billion in 2014, primarily thanks to top spenders Regeneron and Vertex.

Carving Out Their Niche

April 29, 2015 3:59 pm | by Mike Auerbach, Editor in Chief | Blogs | Comments

Enteris BioPharma seeks to stand out from a pack of contract manufacturers with experience, flexibility, and quality. While much of market is focused on mammalian cell cultures, Enteris has “carved out their own niche” in microbial expression systems.

Mannkind Ramping up Production of Inhalable Insulin

April 28, 2015 5:06 pm | by The Associated Press | News | Comments

The company says it is tripling production of its new, fast-acting, inhalable insulin for diabetes at its Danbury plant.

Merck Hurdles Wall Street Forecasts

April 28, 2015 5:02 pm | by LINDA A. JOHNSON, AP Business Writer | News | Comments

Merck easily beat Wall Street expectations despite first-quarter profit plunging 44 percent. The company was hurt by the sale of its consumer health business, unfavorable currency exchange rates and competition to some drugs.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading